Aclaris Therapeutics (ACRS) FCF Margin (2017 - 2026)
Aclaris Therapeutics' FCF Margin came in at -1221.92% for Q2 2026, down 658.38 percentage points from -563.53% a year earlier and down 312.00 percentage points from the prior quarter.
Aclaris Therapeutics (ACRS) FCF Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported FCF Margin of -756.50%, down 696.63 percentage points year-over-year; for FY2025, it was -603.42%, down 495.54 percentage points from FY2024.
- FCF Margin carries a five-year change of -0.43 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -107.88% in FY2024 (+146.95 pp), -254.84% in FY2023 (-25.70 pp), -229.13% in FY2022 (+546.52 pp) and -775.65% in FY2021 (-172.66 pp).
- The Q2 2026 figure represents the lowest quarterly FCF Margin since Q2 2022.
- Year-over-year, FCF Margin has declined for seven consecutive quarters, with an average year-over-year change of -231.83 percentage points over the last eight quarters.
- The fastest year-over-year change in FCF Margin over five years came in Q4 2022 (a gain of 903.00 percentage points), and the weakest in Q4 2025 (a drop of 918.79 percentage points).
- Business Quant data shows ACRS's FCF Margin at -909.92% (Q1 2026), -1015.83% (Q4 2025) and -332.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | -1,626.81% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,626.81% |
| Jun 30, 2026 | -1,221.92% |
| Mar 31, 2026 | -909.92% |
| Dec 31, 2025 | -1,015.83% |
| Sep 30, 2025 | -332.07% |
| Jun 30, 2025 | -563.53% |
| Mar 31, 2025 | -900.34% |
| Dec 31, 2024 | -97.04% |
| Sep 30, 2024 | 506.21% |
| Jun 30, 2024 | -444.97% |
| Mar 31, 2024 | -873.64% |
| Dec 31, 2023 | -40.99% |
| Sep 30, 2023 | -265.47% |
| Jun 30, 2023 | -1,117.44% |
| Mar 31, 2023 | -1,064.32% |
| Dec 31, 2022 | -247.90% |
| Sep 30, 2022 | -41.89% |
| Jun 30, 2022 | -1,299.21% |
| Mar 31, 2022 | -1,454.44% |
| Dec 31, 2021 | -1,150.90% |
Aclaris Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();